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Polymerase stalling results in uncoupling of DNA polymerase and the replicative helicase,
which generates single-stranded DNA (ssDNA). After stalling, RAD51 accumulates at
stalled replication forks to stabilize the fork and to repair by homologous recombination
(HR) double-strand breaks (DSBs) that accumulate there. We showed recently that SUMO
modification of the BLM helicase is required in order for RAD51 to accumulate at stalled
forks. In order to investigate how BLM SUMOylation controls RAD51 accumulation,
we characterized the function of HR proteins and ssDNA-binding protein RPA in cells
that stably expressed either normal BLM (BLM+) or SUMO-mutant BLM (SM-BLM).
In HU-treated SM-BLM cells, mediators BRCA2 and RAD52, which normally substitute
RAD51 for RPA on ssDNA, failed to accumulate normally at stalled forks; instead,
excess RPA accumulated. SM-BLM cells also exhibited higher levels of HU-induced
chromatin-bound RPA than BLM+ cells did. The excess RPA did not result from excessive
intrinsic BLM helicase activity, because in vitro SUMOylated BLM unwound similar
amounts of replication-fork substrate as unSUMOylated BLM. Nor did BLM SUMOylation
inhibit binding of RPA to BLM in vitro; however, in immunoprecipitation experiments, more
BLM-RPA complex formed in HU-treated SM-BLM cells, indicating that BLM SUMOylation
controls the amount of BLM-RPA complex normally formed at stalled forks. Together,
these results showed that BLM SUMOylation regulates the amount of ssDNA that
accumulates during polymerase stalling. We conclude that BLM SUMOylation functions
as a licensing mechanism that permits and regulates HR at damaged replication forks.
Keywords: Bloom′s syndrome, DNA repair foci, homologous recombination, RecQ DNA helicases, replication fork
stability
INTRODUCTION
DNA replication is a fundamental process in all living organ-
isms in which the genetic material is duplicated. Highly regu-
lated checkpoint and DNA repair mechanisms ensure that the
genome is faithfully replicated with each round of cell divi-
sion. In mammalian cells, homologous recombination (HR) is
an essential repair mechanism that stabilizes damaged DNA
replication forks, repairs double-strand breaks (DSBs) that
occur during DNA replication, and helps restore productive
DNA synthesis following disruption or breakage of replication
forks. Although HR is critical in maintaining genome integrity
during replication, it is tightly regulated to avoid harmful
outcomes.
In the autosomal recessive, clinical entity Bloom’s syndrome
(BS), genome integrity is strikingly destabilized due to null muta-
tions in the gene BLM (Ellis et al., 1995). The BLM protein is
an ATP-dependent DNA helicase of the RecQ family, and it pos-
sesses multiple functions in DNA replication and HR (Lambert
et al., 2010; Wechsler et al., 2011). BLM is one of the first compo-
nents to be recruited to sites of DNA replication after treatment
with agents that inhibit fork progression where it is thought
to stabilize stalled forks (Davalos and Campisi, 2003; Sengupta
et al., 2003, 2004). In HR-mediated DSB repair, BLM together
with exonucleases EXO1 and DNA2 promote resection of DSBs,
generating 3′ single-stranded DNA (ssDNA) tails that provide a
substrate for loading of the RAD51 recombinase (Nimonkar et al.,
2008, 2011; Mimitou and Symington, 2009). BLM preferentially
unwinds substrates that resemble recombination intermediates,
such as X-junctions and D-loops, and it is a member of a com-
plex, which includes TopIIIα, BLAP75, and BLAP18 that possesses
the unique capacity to dissolve a late recombination intermedi-
ate, the double Holliday junction, such that only non-crossover
products are generated (Wu and Hickson, 2003; Raynard et al.,
2006; Wu et al., 2006; Bussen et al., 2007; Singh et al., 2008; Xu
et al., 2008). This activity is also important at sites of termination
of DNA replication, because BLM accumulates on late replication
intermediates to assist in duplex separation so that DNA replica-
tion can be efficiently completed (Chan et al., 2007, 2009; Lukas
et al., 2011; Barefield and Karlseder, 2012).
BS cells, which lack BLM activity, display numerous char-
acteristics that are the consequence of excessive HR, includ-
ing high rates of loss of heterozygosity (Langlois et al., 1989;
Groden et al., 1990; LaRocque et al., 2011), excessive chromo-
some abnormalities, such as telomere fusions, ring chromosomes,
and quadriradial chromosomes (German, 1964; German and
Crippa, 1966), and a high rate of sister chromatid exchange
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(SCE)(Chaganti et al., 1974). In addition, BS cells exhibit defects
in DNA replication that might lead to excess HR, including
accumulation of abnormal DNA replication intermediates (Lönn
et al., 1990; Li et al., 2004), slower than normal DNA-chain
growth (Hand and German, 1975; Rao et al., 2007), and abnor-
mal origin firing (Davies et al., 2007). BS cells are hypersensi-
tive to replication inhibitors such as hydroxyurea (HU)(Davies
et al., 2004), and replication forks in BS cells recover inefficiently
from HU-induced stalling, exhibiting accelerated accumulation
of DSBs after release (Davies et al., 2007; Ouyang et al., 2009;
Sidorova et al., 2013).
In our previous work, we showed that BLM undergoes post-
translational modification at lysines K317 and K331 by SUMO-1
and SUMO-2 (Eladad et al., 2005); cells that expressed a GFP-
BLM that was mutated at these two SUMO-acceptor sites, which
we refer to as SUMO-mutant BLM (SM-BLM) cells, exhib-
ited impairments of replication-associated HR, as evidenced by
increased HU-induced DNA damage and reduced HU-induced
SCE (Ouyang et al., 2009). We further showed that SM-BLM
cells have a defect in the recruitment or retention of the RAD51
recombinase at stalled replication forks and that SUMOylation of
BLM in vitro increased the binding efficiency between BLM and
RAD51, suggesting that BLM SUMOylation could act as a switch
to turn on BLM’s function in HR repair of stalled forks (Ouyang
et al., 2009). Although our data indicates that SUMOylation of
BLM regulates the recruitment or retention of RAD51 at stalled
replication forks, the mechanism underlying the defect in RAD51
localization in SM-BLM cells remains unclear.
Replication inhibitors such as HU cause stalling of replicative
polymerases on DNA, uncoupling of the replicative helicase from
polymerases, and the generation of excess ssDNA (Byun et al.,
2005). After HU treatment, excess ssDNA is detectable within
minutes as evidenced by the accumulation of focal concentra-
tions of ssDNA binding protein—replication protein A (RPA)—
at stalled replication forks (Balajee and Geard, 2004; Petermann
et al., 2010). In the HR pathway, RAD51 is normally loaded onto
RPA-bound ssDNA by a process that involves mediators (e.g.,
BRCA2 and RAD52) that substitute RAD51 for RPA on ssDNA
(Heyer et al., 2010); however, after treatment of normal cells with
HU, RAD51 does not accumulate at stalled replication forks for
several hours (Saintigny et al., 2001; Petermann et al., 2010). We
hypothesize that a licensing mechanism exists that controls the
loading of RAD51 onto ssDNA at stalled replication forks. The
licensing mechanism could prevent premature loading of RAD51
at stalled replication forks and activate HR after fork breakage. To
explain the deficit of RAD51 loading at stalled forks in SM-BLM
cells, we hypothesized that SUMOylation of BLM is a key step
in the licensing mechanism. To test this hypothesis, we analyzed
the function of mediators and RPA at stalled forks in HU-treated
SM-BLM cells.
RESULTS
MEDIATOR ACCUMULATION AT STALLED REPLICATION FORKS IS
IMPAIRED IN SUMO-MUTANT BLM CELLS
Because the loading mechanism of RAD51 onto RPA-bound
ssDNA requires recruitment of mediators to the repair site
(Thorslund et al., 2010), we tested whether the mediators BRCA2
and RAD52 localized normally in HU-treated SM-BLM cells.
As expected, treatment of BLM+ cells with 0.5mM HU for
24 h induced an increase in BRCA2 foci from 10.4 foci/cell to
22.9 foci/cell. On the contrary, despite the presence of approx-
imately twice the number of γ-H2AX and BLM foci, untreated
SM-BLM cells exhibited 14.4 BRCA2 foci/cell and HU treatment
failed to induce a significant increase in BRCA2 foci to 16.4
foci/cell (Figure 1A). Similarly, whereas HU treatment of BLM+
cells induced an increase in RAD52 foci from 22.6 foci/cell to
35.1 foci/cell, HU treatment of SM-BLM cells resulted in virtu-
ally no change in RAD52 foci (from 26.4 foci/cell in untreated
cells to 24.9 foci/cell in HU-treated cells; Figure 1B). These data
suggested that the impairment of RAD51 localization in SM-
BLM cells was explained by an upstream defect in mediator
accumulation at stalled forks.
EXCESS RPA ACCUMULATES AT STALLED REPLICATION FORKS IN
SUMO-MUTANT BLM CELLS
Because accumulation of BRCA2 and RAD52 mediators at stalled
forks was impaired after HU treatment, we reasoned that the
impairment could be caused by less ssDNA accumulation after
FIGURE 1 | Mediator accumulation at stalled replication forks is
impaired in SUMO-mutant BLM cells. (A) Immunofluorescence
images of BLM+ and SM-BLM cells untreated (NT) or treated with
0.5mM HU for 24 h (HU) and stained for BRCA2, with graphical
representation of mean numbers of BRCA2 foci. (B) Same as (A) but
stained for RAD52, with graphical representation as in (A). Two
independent experiments were carried out on each of two BLM+ and
two SM-BLM clones. Error bars represent the standard deviations of
the results of each experiment. After treatment with HU, there were
significantly more BRCA2 and RAD52 foci in BLM+ cells (p < 0.001
for both comparisons) but not in SM-BLM cells (p = 0.64 for BRCA2
and p = 0.38 for RAD52). P -values were calculated using mixed
effects linear models as described in Materials and Methods. Bars
indicate 10μm.
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HU treatment. To test this possibility, we compared the accumu-
lation of RPA at stalled forks in SM-BLM and BLM+ cells. We
treated cells with or without 0.5mM HU for 24 h, then quanti-
fied RPA foci by scoring the number of RPA foci/cell (Figure 2A).
Untreated SM-BLM cells exhibited a higher number of RPA foci
than untreated BLM+ cells (21.1 foci/cell vs. 3.7 foci/cell, respec-
tively). HU induced RPA foci in both SM-BLM and BLM+ cells
(105.8 foci/cell vs. 40.5 foci/cell, respectively; Figure 2B). The
absolute increase was 84.7 foci/cell in SM-BLM cells compared
to 36.8 foci/cell in BLM+ cells. We noted that in HU-treated
conditions in both SM-BLM and BLM+ cells, BLM co-localized
to a high degree with a subset of RPA foci. These results ruled
out the possibility that BLM SUMOylation is required for ssDNA
accumulation; on the contrary, SM-BLM cells contained a vast
excess of RPA foci in both untreated and HU-treated conditions.
These data indicated that more ssDNA accumulated at stalled
replication forks in SM-BLM compared to BLM+ cells.
EXCESS CHROMATIN-BOUND RPA IN SM-BLM CELLS
Because SM-BLM cells accumulated excess RPA foci, we pre-
dicted that more RPA would be bound to chromatin. To test this
prediction, we isolated chromatin and nucleoplasmic fractions
from BLM+ and SM-BLM cells untreated or treated with 5mM
HU for 6 h and analyzed extracted proteins by immunoblot. In
untreated conditions, the ratio of chromatin-bound RPA to total
RPA was approximately equal in BLM+ and SM-BLM cells. After
HU treatment, however, RPA shifted from nucleoplasmic frac-
tions to chromatin-bound fractions in response to replication
stress (Figure 3A). The ratio of chromatin-bound RPA to total
RPA increased four fold in SM-BLM cells compared to two fold
in BLM+ cells (Figure 3B). The increased amount of chromatin-
bound RPA after HU treatment in SM-BLM cells was consistent
FIGURE 2 | Excess RPA accumulates at stalled replication forks in
SUMO-mutant BLM cells. (A) Immunofluorescence images of BLM+ and
SM-BLM cells untreated (NT) or treated with 0.5mM HU for 24 h (HU) and
stained for RPA. Bars indicate 10μm. (B) Graphical representation of mean
numbers of RPA foci. Three independent experiments were carried out for
each of two BLM+ and two SM-BLM clones. Error bars represent the
standard deviations of the results of each experiment. There were
significantly more RPA foci in SM-BLM cells compared to BLM+ cells
(p < 0.001) and HU treatment induced significantly more RPA foci in both
cell lines (p < 0.001). Interaction was also observed indicating that the
difference in effect of HU treatment on the two cell lines is significant
(pint = 0.002). P -values were calculated using mixed effects linear models
as described in Materials and Methods.
with the indirect immunofluorescence data that showed the accu-
mulation of excess RPA foci. Together, these data indicated that
BLM SUMOylation functions to limit the formation of excess
RPA-ssDNA complex at stalled replication forks.
DNA HELICASE ACTIVITY OF SUMOYLATED BLM IS NORMAL
The excessive accumulation of fork-associated RPA raised the
possibility that excess ssDNA was generated at stalled forks in
SM-BLM cells due to a failure to suppress BLM’s DNA unwind-
ing activity at the fork. To test this hypothesis, we compared
the DNA helicase activity of SUMOylated and unSUMOylated
BLM in vitro. Purified His-tagged BLM helicase was SUMOylated
in vitro using purified human E1, UBC9, and SUMO-2 in
a reaction that required ATP. After incubation of the BLM
with reaction components for 2 h, >95% of the BLM was
SUMOylated, and multiple moieties of SUMO-2 were attached
to most of the BLM (Figure 4A). We then compared heli-
case activity of the SUMOylated and unSUMOylated BLM in
two ways: (1) BLM SUMOylation reactions were prepared with
or without ATP and reaction products were added directly to
helicase assays; or, (2) SUMOylated and unSUMOylated BLM
was partially purified from the SUMO reaction components by
pull-down on nickel-NTA beads, after which bead-bound BLM
was added to helicase assays. BLM activity was assayed on a
32P-labeled DNA replication-fork-like substrate (38-nucleotide
duplex DNA with two 12-nucleotide ssDNA tails) and per-
cent unwinding was measured by electrophoresis through non-
denaturing polyacrylamide gels followed by autoradiography.
In both types of experiment, the percent of DNA substrate
unwound over time was indistinguishable for SUMOylated com-
pared to unSUMOylated BLM (Figures 4B,C). These results
showed that BLM SUMOylation does not function to suppress
BLM’s intrinsic DNA helicase activity. Therefore, the excessive
accumulation of fork-associated RPA in SM-BLM cells was not
the result of failure to suppress BLM’s intrinsic DNA helicase
activity.
FIGURE 3 | Increased levels of RPA accumulate on chromatin in
HU-treated SM-BLM cells. BLM+ and SM-BLM cells were untreated or
treated with 5mM for 6 h. (A) Chromatin and nucleoplasmic fractions were
isolated from cells and solubilized RPA was analyzed by immunoblot using
antibodies to the p34 subunit. Orc2 was used for quality control of the
preparation of the chromatin-bound fraction. (B) Graph depicting the ratio of
chromatin-bound RPA to nucleoplasmic RPA. A minimum of two
independent experiments were carried out on each of two BLM+ and two
SM-BLM clones. Error bars represent the standard deviations of the
combined data.
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FIGURE 4 | DNA helicase activity of SUMOylated BLM is similar to
unSUMOylated BLM. (A) BLM SUMOylation reactions were carried out,
time points were removed, and the reactions were stopped with sample
buffer. The reaction products were analyzed by sodium dodecyl
sulphate-polyacrylamide gel electrophoresis followed by silver staining. (B)
SUMOylated (SUMO-BLM) or unSUMOylated BLM (BLM) was prepared by
incubating 200 ng of purified recombinant BLM with SUMO reaction
components in the presence (to make SUMOylated BLM) or absence (to
make unSUMOylated BLM) of ATP. Helicase assays were performed by
incubating the SUMO reaction products with 32P-labeled synthetic
replication-fork substrate, and the helicase reactions were stopped at
different times. The products were analyzed by non-denaturing
polyacrylamide gel electrophoresis followed by autoradiography. The
position of the forked duplex and the unwound product are indicated on the
left. S, unreacted substrate; B, beads only with unreacted substrate; ,
boiled substrate; BLM (no rx comp), helicase reactions performed with BLM
protein that was not exposed to SUMO reaction components as a positive
control. (C) Graph showing quantification of the percentage of unwound
substrate by SUMOylated and unSUMOylated BLM prepared in these
experiments by nickel-NTA pull down. A minimum of two DNA unwinding
experiments were performed for each method of BLM SUMOylation
preparation shown in (B) and (C).
EXCESS BLM-RPA COMPLEX FORMS IN SM-BLM CELLS
BLM interacts with the 70 kD subunit of RPA (RPA-70), and RPA
stimulates BLM’s DNA helicase activity (Brosh et al., 2000). If
BLM SUMOylation functions to inhibit BLM-RPA interaction,
then excess RPA accumulation in SM-BLM cells could result from
a failure to suppress BLM-RPA interaction. To test this hypoth-
esis, we compared the binding of purified RPA to SUMOylated
or unSUMOylated BLM in vitro. BLM SUMOylation reactions
were prepared with or without ATP, reaction products weremixed
with RPA, and BLM-RPA complexes were pulled down with
nickel-NTA beads. The amount of BLM-bound RPA was then
measured by immunoblot analysis with anti-RPA/p70 antibod-
ies. In these assays, the amount of BLM-bound RPA-70 detected
was the same whether or not BLM was SUMOylated (Figure 5A).
These data suggested that BLM SUMOylation does not directly
affect interaction between BLM and RPA.
Because BLM SUMOylation could affect BLM and RPA inter-
action indirectly, we compared BLM-RPA complex formation
in vivo by immunoprecipitation of BLM from HU-treated and
untreated BLM+ vs. SM-BLM cells. In untreated cells, little to
no detectable RPA was pulled down with BLM in either cell line.
However, in HU-treated cells, more RPA was pulled down with
BLM in SM-BLM cells compared to BLM+ cells (Figure 5B).
Finding increased BLM-RPA complex formation in SM-BLM
cells correlated with the excessive accumulation of RPA foci in
SM-BLM cells, and it suggested that BLM SUMOylation has a
role in preventing the accumulation of excess ssDNA at stalled
forks.
To test whether the increased BLM-RPA complex formation
in SM-BLM cells was trivially a consequence of higher levels of
RPA expression in these cells, we performed immunoblot anal-
ysis of untreated and HU-treated SM-BLM and BLM+ cells.
Analysis of total cell extracts indicated that SM-BLM and BLM+
cells contained similar amounts of RPA protein with or without
treatment with HU (Figure 5C). Together with the in vitro data,
the results suggested that BLM SUMOylation affects BLM-RPA
complex formation indirectly, possibly through the mediation of
other proteins at the fork. We concluded that BLM SUMOylation
regulates BLM-RPA interaction at stalled forks.
In these experiments, we noted that HU-induced RPA phos-
phorylation did not differ significantly between BLM+ and SM-
BLM cells, despite the presence of excess RPA at stalled forks in
SM-BLM cells (Figure 5C).
DISCUSSION
The data presented here demonstrated that BLM SUMOylation
regulates RPA and mediator accumulation at stalled replication
forks, limiting the generation of excess ssDNA there. In HU-
treated SM-BLM cells, a large excess of ssDNA accumulated at
stalled forks, as evidenced by excess RPA foci and greater amounts
of chromatin-bound RPA. With so much ssDNA generated at
stalled forks in SM-BLM cells, we would expect large accumu-
lations at the fork of both mediators BRCA2 and RAD52, and
RAD51 as well. On the contrary, these proteins did not accumu-
late normally at stalled forks. These two observations are therefore
evidence that BLM SUMOylation is necessary to license the
HR mechanism at stalled forks, as mediator-dependent RAD51
complexes did not form on RPA-coated ssDNA in its absence.
Because RAD51 loading onto ssDNA depends on mediator func-
tion, our results explain why RAD51 is not recruited to stalled
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FIGURE 5 | Excess BLM-RPA complex forms in SM-BLM cells. (A)
SUMOylation of BLM did not affect BLM-RPA binding in vitro. SUMOylated
(SUMO-BLM) or unSUMOylated (BLM) BLM were bound to Ni-NTA beads
and incubated with increasing amounts of purified human RPA protein for
30min at room temperature. The beads were washed three times. Bound
RPA protein was analyzed by immunoblot with anti-RPA/p70 antibody. A
bead-only experiment showed that no excess RPA bound to beads in the
absence of BLM. (B) BLM binds more RPA in SM-BLM cells than BLM+
cells. Cells were untreated or treated with 5mM HU for 6 h.
Immunoprecipitation of RPA was carried out using antibodies to the GFP
tag on GFP-BLM. Input consisted of 2% of the initial cell extracts. Hsc70
was used as a loading control. A minimum of two independent
experiments were carried out for each of two BLM+ and two SM-BLM
clones. The graph depicts the ratio of input and immunoprecipitated RPA in
HU-treated SM-BLM cells over HU-treated BLM+ cells. (C) HU does not
induce significantly different levels of RPA and phosphorylated RPA in
SM-BLM cells compared to BLM+ cells. Cells were untreated or treated
with 5mM HU for 6 h. Whole cell lysates were extracted and analyzed by
immunoblot with antibodies to the p34 subunit of RPA. Hsc70 was used as
a loading control. A minimum of two independent experiments were
carried out for each of two BLM+ and of two SM-BLM clones. Error bars
represent the standard deviations of the combined data.
forks in SM-BLM cells; however, the mechanism explaining why
mediators are not recruited is still enigmatic.
The uncoupling of DNA replication from the replicative heli-
case during fork stalling can lead to extended stretches of ssDNA
and later to replication-associated DSBs that could be processed
by exonucleases (Petermann and Helleday, 2010). Because RPA-
ssDNA complexes form on both of these cellular substrates, we
do not know a priori whether BLM SUMOylation is impor-
tant before or after the replication fork breaks. In our pre-
vious work (Ouyang et al., 2009), we showed that 24-h HU
treatment of SM-BLM cells did not lead to increased DSBs in
comparison to untreated SM-BLM cells. Moreover, the effect
of BLM SUMOylation on RAD51 accumulation at stalled forks
was apparent after a 1-h HU treatment of SM-BLM cells before
DSBs have had a chance to accumulate (Saintigny et al., 2001;
Petermann et al., 2010). Therefore, these data suggest that BLM
SUMOylation is important in the generation of ssDNA after
helicase-polymerase uncoupling and before fork breakage.
Formally speaking, the function of BLM SUMOylation in HR
licensing at the fork could result from either positive or negative
regulatory effects or both. Previous work has shown that RPA
interacts with BLM, inhibiting BLM’s strand annealing activity
while increasing the efficiency of its helicase activity (Brosh et al.,
2000; Doherty et al., 2005; Bartos et al., 2006). SUMOylation
did not inhibit BLM-RPA interaction in vitro, yet more BLM-
RPA complex formed in SM-BLM cells than in BLM+ cells after
replication stress. Intriguingly, RPA is SUMOylated by SUMO-
2 after treatment with camptothecin (CPT), which generates
replication-associated DSBs (Dou et al., 2010). Cells that express
a SUMO-mutant RPA have defects in RAD51 accumulation and
DSB repair at IR-induced DSBs and CPT-induced broken forks;
but increased RPA SUMOylation was not reported to occur dur-
ing replication stress with UV or HU treatment (Dou et al.,
2010). Thus, SUMOylation of BLM and RPA seem to have sim-
ilar effects on the accumulation of RAD51, one in the context
of replication fork stalling and the other in the context of repli-
cation fork breakage. Further studies are needed to examine the
role of SUMOylation on the interaction of RPA and BLM and
the possible effects of SUMOylation on each protein’s biochemical
activities.
In normal cells, the amount of ssDNA that accumulates after
replication stalling is regulated by damage sensing and check-
point pathways that recruit proteins to stabilize the fork and
inhibit further unwinding (Sleeth et al., 2007). Because BLM pro-
tein is recruited to the fork immediately after stalling occurs,
it is possible that pathologically unrestricted SM-BLM protein
generates excessive DNA unwinding at the fork. We showed
that BLM helicase activity is not inhibited by SUMOylation;
therefore, if SUMOylation prevents BLM from unwinding DNA
at the fork, it must do so via interaction with another pro-
tein. Because RPA stimulates BLM helicase activity, it is possible
that SUMOylation negates RPA’s stimulatory effect. Alternatively,
BLM SUMOylation could have an indirect effect on the accu-
mulation of RPA-ssDNA complex through interaction with ATR-
mediated checkpoint signaling.
Another possibility is that BLM SUMOylation activates BLM
or another protein’s ssDNA annealing activity. A novel ssDNA
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annealing function was recently identified in the N-terminal por-
tion of BLM distinct from an annealing activity reported for
the helicase domain (Chen and Brill, 2010); this region coin-
cides with the region containing the SUMO-acceptor sites and the
region required for SUMObinding (Eladad et al., 2005; Zhu et al.,
2008). This ssDNA annealing activity of BLM could function to
stabilize stalled forks by reannealing excess ssDNA. The anneal-
ing helicase HARP (HepA-related protein) has a role in ssDNA
annealing that leads to stabilization of stalled forks (Bansbach
et al., 2009; Driscoll and Cimprich, 2009; Yuan et al., 2009),
and BLM SUMOylation could de-repress or directly promote the
activities of these proteins (Yusufzai and Kadonaga, 2008, 2010;
Sen et al., 2012).
Many key components and functions of the HR machinery
are highly conserved. An exception to this rule lies with medi-
ator proteins. While Rad52 is an essential component in yeast
HR (Pâques and Haber, 1999), RAD52 gene knockout in mice
shows no significant effect on cell viability or on HR and DNA
repair capacities (Rijkers et al., 1998; Yamaguchi-Iwai et al., 1998).
Instead, the BRCA2 mediator protein, a component that is not
present in budding yeast, plays a central role in mammalian
DSB repair by HR (Xia et al., 2001; Yang et al., 2005; Carreira
et al., 2009). Recent work has shown that RAD52 inactivation is
synthetically lethal with BRCA2 deficiency in human cell lines,
indicating overlapping functions between RAD52 and BRCA2
in RAD51-dependent HR repair (Feng et al., 2011). Some have
suggested that RAD52’s primary function is not in the repair of
DSBs with two broken ends but in the protection and repair of
stalled and broken replication forks (Wray et al., 2008; Feng et al.,
2011). Our results showed that SM-BLM cells have a defect in
the accumulation of both RAD52 and BRCA2 at stalled forks,
indicating that BLM SUMOylation is necessary for efficient medi-
ator recruitment to stalled replication forks. We note that RAD52
is SUMOylated by the MMS21 E3 ligase, which is part of the
SMC5/6 complex, and RAD52’s SUMOylation is required for its
normal repair function (Sacher et al., 2006; Santa Maria et al.,
2007; Torres-Rosell et al., 2007; Ohuchi et al., 2008; Altmannova
et al., 2010). Recent work has indicated that mediators, RAD51,
and the Fanconi anemia complex have functions in replication
fork stabilization that are independent of their roles in DSB repair
(Schlacher et al., 2011, 2012; Feng and Zhang, 2012). RAD52 has
ssDNA annealing activity that could help stabilize the replica-
tion fork (Wu et al., 2008; Grimme et al., 2010); consequently,
the failure to recruit mediators to stalled forks in SM-BLM cells
could explain the accumulation of excess RPA-ssDNA, if media-
tors are required for ssDNA annealing at the fork, or it could be
an independent consequence of unSUMOylated BLM activity at
the stalled fork.
While excess accumulation of RPA in HU-treated SM-BLM
cells could result from either excessive DNA unwinding or
impaired ssDNA re-annealing, there is yet another possible expla-
nation relating to replication dynamics. Work in yeast and
mammalian cells has shown that replication forks collapsed by
prolonged replication stalling do not restart, and replication
is rescued instead by new origin firing (Davies et al., 2007;
Petermann et al., 2010). In SM-BLM cells, stalled replication forks
may collapse more readily, leading to initiation of new forks to
compensate for the loss. In this model, the excess RPA foci would
be accounted for by activation of dormant replication origins.
The SUMO pathway prevents aberrant recombination events
from occurring at damaged replication forks. It positively regu-
lates DSB repair by HR (Liberi et al., 2005; Branzei et al., 2006;
Burgess et al., 2007) and it can influence repair pathway choice
(Ulrich, 2009; Yang et al., 2011). Multiple components of the
HR pathway are SUMOylated, but in most cases a complete
mechanistic understanding of SUMO’s role in functional reg-
ulation of its substrates is lacking. Protein-protein interactions
between SUMO binding sites and SUMOs could be important
in the recruitment of DNA repair factors such as 53BP1 and
BRCA1 to the repair site (Bergink and Jentsch, 2009; Galanty
et al., 2009; Morris et al., 2009). Recent work on the SUMO-
targeted ubiquitin ligase RNF4 has suggested that SUMOylation
could be important for dissociation of proteins such as MDC1
from the repair site (Galanty et al., 2012; Luo et al., 2012; Yin
et al., 2012; Vyas et al., 2013), but ubiquitylation by RNF4 could
also serve to recruit proteins with ubiquitin-binding sites by mak-
ing hybrid SUMO-ubiquitin chains (Guzzo et al., 2012). From all
these studies, SUMO seems to govern important turnover transi-
tions, promulgating cycles of association and dissociation at the
repair site: BLM SUMOylation could both assist in the recruit-
ment of factors like RAD52 and RAD51 and it could also remove
BLM from the repair site; both of these roles for SUMOylation
would be absent in the SM-BLM protein.
BLM has many functions throughout the processes of DNA
replication andHR repair. How these functions are regulated is an
important question. SUMOylation is a dynamic process that con-
fers diverse and unique roles to its substrate proteins. The present
work shed light on how BLM SUMOylation regulates RPA and
mediator functions at stalled forks, and more broadly, how repli-
cation forks are maintained under stress when HR is called into
play. Our evidence suggests that BLM SUMOylation functions
as a licensing mechanism that regulates and permits execution
of the HR mechanism at damaged replication forks. The next
step is to dissect the specific recruitment and turnover functions
of SUMOylation on BLM and other proteins in this licensing
mechanism.
MATERIALS AND METHODS
ANTIBODIES
For BLM immunoblot analysis, rabbit polyclonal anti-BLM
antibodies raised against the first 431 amino acids of human
BLM (Beresten et al., 1999) were used. For other immunoblot
analyses, rabbit polyclonal anti–γ-H2AX antibodies (Abcam),
mousemonoclonal anti-RPA/p34 antibody (Neomarkers), mouse
monoclonal anti-RPA/p70 antibody (Neomarkers), rat mon-
oclonal anti-ORC2 antibody (Abcam), and rat monoclonal
anti-Hsc70 antibody (Assay Design) were used. Horseradish
peroxidase-linked anti-mouse, anti-rabbit (Amersham), and
anti-rat (Jackson ImmunoResearch) antibodies were used as
secondary antibodies. Agarose conjugated rat monoclonal anti-
GFP antibody D153-8 (MBL) was used for immunoprecipitation
experiments. For indirect immunofluorescence, we used mouse
monoclonal anti–γ-H2AX antibody (Upstate), rabbit polyclonal
anti-RAD51 antibodies PC130 (Calbiochem), rabbit polyclonal
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anti-RAD52 antibodies sc-8250 (Santa Cruz Biotechnology),
mouse anti-BRCA2 antibodies 05-666 (Millipore), mouse mono-
clonal anti-RPA/p34 antibody (Neomarkers), Cy-5–labeled don-
key anti-rabbit antibodies (Jackson ImmunoResearch), Alexa
Fluor 594-labeled goat anti-mouse, Alexa Fluor 594-labeled goat
anti-rabbit, and Alexa Fluor 647-labeled goat anti-mouse anti-
bodies (Invitrogen).
IMMUNOFLUORESCENCE AND IMAGE ANALYSIS
The generation and characterization of BLM+ and SM-BLM cells
was described previously (Eladad et al., 2005;Ouyang et al., 2009).
Briefly, the SV40-transformed BS fibroblast cell line GM08505
was transfected with normal GFP-BLM or the SM-GFP BLM
expression constructs, clones were isolated and selected for anal-
ysis that expressed similar amounts of GFP-BLM proteins. For
indirect immunofluorescence, BLM+ and SM-BLM cells were
seeded on coverslips and then treated with 0.5mMHU in culture
medium for 24 h. At the end of HU treatment, cells were washed
and fixed and then stained with anti-RAD51,−BRCA2,−RAD52,
or −RPA antibodies, and counterstained with appropriate sec-
ondary antibodies labeled with Alexa Fluor (Invitrogen). Fixation
and staining was performed as described previously (Eladad
et al., 2005; Ouyang et al., 2009). Coverslips were mounted
with Prolong Gold antifade reagent containing 4′,6-diamidino-
2-phenylindole (DAPI; Invitrogen). Images were captured on a
spinning disk confocal microscope (Carl Zeiss, LSM-510), and
data were collected using Slidebook 4.1 software. Z-stacks were
captured using a 100× oil immersion objective and the optical
slice thickness was 0.2μm. The BRCA2 data was collected on a
laser-scanning confocal microscope (Carl Zeiss, LSM-710) and a
single plane was imaged.
A focus was defined as a defined area of the nucleus greater
than the minimum area of optical resolution (>0.125μm2) in at
least one Z-stack in which the fluorescence intensity was greater
than the background fluorescence intensity of the nucleoplasm.
The maximum number of foci that could be counted in these cells
was 150. A typical immunofluorescence experiment consisted of
assessment of 30–50 cells per condition. The data presented are
from two to three independent experiments performed on two to
three clones of each type. Immunofluorescence images for figures
were created using Image J and Metamorph software (Molecular
Devices).
IMMUNOBLOT ANALYSES
Proteins from cell lysates, chromatin, and nucleoplasmic frac-
tions, and immunoprecipitates were separated on 4–15% sodium
dodecyl sulphate (SDS)/polyacrylamide gradient gels (Bio-Rad)
and transferred on to polyvinylidene fluoride membranes (Bio-
Rad). The membranes were blocked for 1 h at room temperature
with Tris-buffered saline (Boston Bioproducts) containing 0.1%
Tween 20 and 5% powdered milk (Bio-Rad), washed, and sub-
sequently probed with appropriate primary antibodies either
for 2 h at room temperature or overnight at 4◦C. The mem-
branes were then incubated with the appropriate horseradish
peroxidase-linked secondary antibodies for 1 h at room tem-
perature, washed, and incubated with Western Lightning–ECL,
Enhanced Chemiluminescence reagent (Perkin Elmer) for 5min
at room temperature. Proteins labeled with antibodies on the
membrane were visualized by detection on film.
CHROMATIN ISOLATION
Chromatin preparations were made by the method of Méndez
and Stillman (2000). Briefly, cells treated with or without 5mM
HU for 6 h were harvested by centrifugation, washed in PBS,
and resuspended in buffer A (10mM HEPES, pH 7.9, 10mM
KCl, 1.5mM MgCl2, 0.34M sucrose, 10% glycerol, 1mM DTT,
0.1mM PMSF, and protease inhibitors cocktail). Triton X-100
(0.1%) was added, and the cells were incubated for 5min on ice.
Nuclei were collected in the pellet by low-speed centrifugation at
1300 × g for 4min at 4◦C. Nuclei were washed once in buffer A,
and then lysed in buffer B (3mM EDTA, 0.2mM EGTA, 1mM
DTT, protease inhibitors cocktail). Nucleoplasmic proteins were
separated from chromatin-bound proteins by centrifugation at
1700 × g for 5min at 4◦C. Nucleoplasmic fractions were col-
lected in the supernatant. The chromatin pellet was washed once
in buffer B, and centrifuged again under the same conditions.
The final chromatin pellet was resuspended in Laemmli sample
buffer. HU treatment was performed at 5mM for 6 h so that BLM
quantities would be nearly the same in untreated and treated cells.
With respect to the phenotypes studied here, there are no major
differences between the 6− and 24-h treatments (Ouyang et al.,
2009).
IMMUNOPRECIPITATION
Cells treated with or without 5mM HU for 6 h were harvested,
washed twice in PBS buffer, and resuspended in NP-40 lysis buffer
(Boston Bioproducts) containing protease inhibitors (Roche)
for 30min. Cell lysates were cleared by centrifugation (15min,
14,000 × g, 4◦C). Cleared cell lysates were then incubated with
20μl of agarose beads conjugated with anti-GFP antibodies and
allowed to mix overnight at 4◦C. Proteins bound to beads were
separated from the supernatant by centrifugation (3min, 2000 ×
g, 4◦C) and washed with 5 times volume of lysis buffer. Proteins
were extracted from the beads by boiling in Laemmli buffer
(Boston Bioproducts) for 5min and subsequently analyzed by
immunoblot.
SUMOYLATION OF BLM
Two hundred nanograms of His-tagged full-length BLM, purified
according to the method of Karow et al. (1997), was SUMOylated
in a 50μl reaction containing 10mM HEPES (pH 7.3), 110mM
potassium acetate, 2mMMgCl2, 2mM ATP, and purified recom-
binant proteins (Zhu et al., 2008), including 200 ng E1, 100 ng
UBC9, and 200 ng SUMO-2, at 37◦C for increasing amounts of
time (0.5, 1, 2, 5, 10, 15, 30, 45, 60, and 120min). Reactions
were stopped by the addition of sample buffer and subsequently
analyzed by SDS-polyarcylamide gel electrophoresis followed by
Silver staining (Pierce Silver Stain Kit, Thermo Scientific) per the
manufacturer’s instructions.
DNA SUBSTRATE
Oligonucleotides for the fork substrate designed according to
Mohaghegh et al. (2001) were purchased from Integrated DNA
Technologies. A single oligonucleotide was 5′-end-labeled with
[γ−32P]ATP (PerkinElmer Life Sciences) using T4 polynucleotide
kinase in PNK buffer at 37◦C for 30min per the manufac-
turer’s instructions (New England Biolabs). The labeled substrate
was purified using QIAquick Nucleotide Removal kit (Qiagen).
The [γ-32P]ATP-labeled oligonucleotide was then annealed
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with a two fold excess of the unlabeled complementary oligonu-
cleotide in annealing buffer (40mM Tris-HCl, pH 8.0, 50mM
NaCl) by heating at 95◦C for 5min and then cooling slowly to
room temperature.
HELICASE ASSAY
Equal amounts of SUMOylated BLM and unSUMOylated BLM,
respectively, were added to 100μl of nickel-NTA bead slurry
(Qiagen) that had been blocked in 0.5% BSA for 2 h at room
temperature and then washed two times in BLM binding buffer
(60mM Tris-HCl, pH 7.4, 20mMKCl). BLM was bound to beads
for 1 h at room temperature and washed two times in BLM bind-
ing buffer. Helicase reactions were performed with 20 ng BLM
in 10mM Tris-HCl (pH 7.5), 4mMMgCl2, 1mM dithiothreitol,
2mM ATP, 0.1mg/ml BSA, and 0.3 nM of labeled helicase sub-
strate at 37◦C for either 5, 10, 15, 20, 30, 40, or 60min. Helicase
reactions were stopped by adding gel loading dye (50mM
EDTA, 40% glycerol, 0.9% SDS, 0.05% bromophenol blue,
and 0.05% xylene cyanol). Reaction products were analyzed by
electrophoresis through pre-cast 10% non-denaturing polyacry-
lamide gels (Bio-Rad). The amount of substrate unwound was
measured by autoradiography using a phoshorimager (Molecular
Dynamics).
In vitro BINDING ASSAY
Two hundred nanograms of SUMOylated and unSUMOy-
lated BLM, respectively, were added to 200μl of Ni-NTA
bead slurry (Qiagen) that had been previously incubated in
Blocking Buffer (PBS, 0.5% Tween 20, 3% BSA) for 2 h at
room temperature and subsequently washed three times with
PBS. Increasing concentrations of purified RPA were then incu-
bated with 20 ng of either SUMOylated BLM or unSUMOy-
lated BLM bound to nickel-NTA beads, respectively, in binding
Buffer (50mM Tris-HCl, pH 7.4, 5mM MgCl2, 5mM ATP,
100μg/ml BSA, and 50mM NaCl) for 30min at room temper-
ature. Beads were then washed three times in binding buffer.
The amount of RPA-70 protein bound to SUMOylated BLM
or unSUMOylated BLM was analyzed by immunoblot with
anti-RPA/p70 antibodies.
STATISTICAL ANALYSIS
Because observations within each clone may be correlated, we
used mixed effects linear models to test the data for statistical
significance. In the mixed effects models, each clone was treated
as a random effect and the experimental variables were treated
as fixed effects. For testing changes in the number of foci/cell,
cell type (BLM or SM), treatment (with and without HU), and
interaction terms for cell type by treatment were treated as fixed
effects. Because the foci data were not normally distributed,
we used a generalized estimating equation approach that can
account for non-normal correlated data with non-homogeneous
variances.
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